PortfoliosLab logo
Advanced Medical Solutions Group plc (AMS.L)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

GB0004536594

Highlights

Market Cap

£464.40M

EPS (TTM)

£0.03

PE Ratio

71.67

PEG Ratio

5.00

Total Revenue (TTM)

£177.52M

Gross Profit (TTM)

£86.04M

EBITDA (TTM)

£26.86M

Year Range

£1.72 - £272.32

Target Price

£267.29

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

S&P 500

Returns By Period

Advanced Medical Solutions Group plc (AMS.L) returned 10.33% year-to-date (YTD) and -0.10% over the past 12 months. Over the past 10 years, AMS.L returned 6.53% annually, underperforming the S&P 500 benchmark at 11.14%.


AMS.L

YTD

10.33%

1M

11.35%

6M

2.36%

1Y

-0.10%

3Y*

-9.58%

5Y*

-2.13%

10Y*

6.53%

^GSPC (Benchmark)

YTD

2.39%

1M

3.05%

6M

-1.02%

1Y

12.04%

3Y*

15.58%

5Y*

14.64%

10Y*

11.14%

*Annualized

Monthly Returns

The table below presents the monthly returns of AMS.L, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20255.77%1.44%9.43%-16.81%3.34%9.31%10.33%
20240.96%0.24%-6.67%-3.37%15.49%-1.38%14.95%1.63%-12.90%4.38%-5.96%-7.23%-3.68%
2023-1.93%-1.57%-11.00%10.11%-8.02%0.89%9.96%2.62%-20.89%-3.58%4.23%2.72%-19.11%
2022-12.72%-2.03%2.94%-5.71%7.82%-1.99%-5.08%7.50%-18.73%11.89%0.18%-5.30%-22.81%
2021-6.38%3.30%-0.64%21.41%-2.93%3.65%-1.06%-5.34%16.21%5.35%-1.23%5.30%39.98%
2020-4.73%-9.93%-1.18%-2.79%2.50%-4.42%-19.33%25.26%-10.18%-2.55%16.90%-1.02%-17.34%
201910.73%0.16%3.77%4.27%4.36%-12.66%-2.67%7.53%-21.34%-1.01%6.97%13.41%8.13%
20182.28%0.00%-2.62%-0.32%3.72%0.31%10.08%-5.69%11.52%-13.16%1.92%-5.98%-0.48%
2017-9.81%6.75%13.35%9.09%8.39%1.58%2.67%6.72%-8.70%19.59%-9.24%1.03%43.79%
2016-5.66%1.02%5.07%0.55%9.51%-2.13%10.77%2.78%2.84%-6.69%5.29%-1.00%22.87%
20155.19%7.40%-4.59%5.00%6.18%-4.67%5.59%-0.66%2.33%7.01%4.27%5.99%45.44%
201412.70%-9.02%13.06%-0.67%-6.64%-4.96%0.45%14.00%-3.37%-3.10%1.06%5.03%16.30%
Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of AMS.L is 68, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of AMS.L is 6868
Overall Rank
The Sharpe Ratio Rank of AMS.L is 4747
Sharpe Ratio Rank
The Sortino Ratio Rank of AMS.L is 100100
Sortino Ratio Rank
The Omega Ratio Rank of AMS.L is 100100
Omega Ratio Rank
The Calmar Ratio Rank of AMS.L is 4747
Calmar Ratio Rank
The Martin Ratio Rank of AMS.L is 4747
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Advanced Medical Solutions Group plc (AMS.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Advanced Medical Solutions Group plc Sharpe ratios as of Jun 12, 2025 (values are recalculated daily):

  • 1-Year: 0.00
  • 5-Year: -0.00
  • 10-Year: 0.00
  • All Time: 0.00

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Advanced Medical Solutions Group plc compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

Dividend History

Advanced Medical Solutions Group plc provided a 1.20% dividend yield over the last twelve months, with an annual payout of £0.03 per share. The company has been increasing its dividends for 5 consecutive years.


0.00%5.00%10.00%15.00%£0.00£0.10£0.20£0.30£0.4020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
Dividend£0.03£0.02£0.02£0.02£0.02£0.02£0.01£0.43£0.01£0.01£0.01£0.01

Dividend yield

1.20%1.23%1.07%0.78%0.53%0.64%0.47%15.70%0.31%0.38%0.40%0.50%

Monthly Dividends

The table displays the monthly dividend distributions for Advanced Medical Solutions Group plc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025£0.00£0.00£0.00£0.00£0.02£0.00£0.02
2024£0.00£0.00£0.00£0.00£0.02£0.00£0.00£0.00£0.01£0.00£0.00£0.00£0.02
2023£0.00£0.00£0.00£0.00£0.02£0.00£0.00£0.00£0.01£0.00£0.00£0.00£0.02
2022£0.00£0.00£0.00£0.00£0.01£0.00£0.00£0.00£0.01£0.00£0.00£0.00£0.02
2021£0.00£0.00£0.00£0.00£0.01£0.00£0.00£0.00£0.01£0.00£0.00£0.00£0.02
2020£0.00£0.00£0.00£0.00£0.01£0.00£0.00£0.00£0.01£0.00£0.00£0.00£0.02
2019£0.00£0.00£0.00£0.00£0.01£0.00£0.00£0.00£0.01£0.00£0.00£0.00£0.01
2018£0.00£0.00£0.00£0.00£0.01£0.00£0.00£0.00£0.42£0.00£0.00£0.00£0.43
2017£0.00£0.00£0.00£0.00£0.01£0.00£0.00£0.00£0.00£0.00£0.00£0.00£0.01
2016£0.00£0.00£0.00£0.00£0.01£0.00£0.00£0.00£0.00£0.00£0.00£0.00£0.01
2015£0.00£0.00£0.00£0.00£0.00£0.00£0.00£0.00£0.00£0.00£0.00£0.00£0.01
2014£0.00£0.00£0.00£0.00£0.00£0.00£0.00£0.00£0.00£0.01

Dividend Yield & Payout


Dividend Yield

Advanced Medical Solutions Group plc has a dividend yield of 1.20%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.

Payout Ratio

Advanced Medical Solutions Group plc has a payout ratio of 74.77%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Advanced Medical Solutions Group plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Advanced Medical Solutions Group plc was 99.48%, occurring on Apr 25, 2025. The portfolio has not yet recovered.

The current Advanced Medical Solutions Group plc drawdown is 35.77%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.48%May 29, 20191494Apr 25, 2025
-98%Mar 18, 19971401Jul 30, 20023827Aug 9, 20175228
-43.09%Jan 24, 199561Apr 18, 1995122Oct 5, 1995183
-31.93%Jul 5, 199693Nov 12, 199643Jan 10, 1997136
-29.84%Oct 6, 199553Dec 19, 199523Jan 19, 199676
Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Advanced Medical Solutions Group plc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Advanced Medical Solutions Group plc is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for AMS.L, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, AMS.L has a P/E ratio of 71.7. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for AMS.L compared to other companies in the Medical Instruments & Supplies industry. AMS.L currently has a PEG ratio of 5.0. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for AMS.L relative to other companies in the Medical Instruments & Supplies industry. Currently, AMS.L has a P/S ratio of 2.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for AMS.L in comparison with other companies in the Medical Instruments & Supplies industry. Currently, AMS.L has a P/B value of 1.9. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items